Disc Medicine (NASDAQ:IRON) Price Target Raised to $73.00 at Stifel Nicolaus

Disc Medicine (NASDAQ:IRON – Free Report) had its price target boosted by Stifel Nicolaus from $71.00 to $73.00 in a research note released on Monday, Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock. IRON has been the subject of several other research reports. Wedbush reiterated an outperform rating and set a […]

Related Keywords

United States ,Stifel Nicolaus ,Citadel Advisors ,First Turn Management ,Blackrock Inc ,Cantor Fitzgerald ,Disc Medicine Inc ,Venture Fund Xlp Atlas ,Morgan Stanley ,Sphera Funds Management ,Perceptive Advisors ,Disc Medicine ,Free Report ,Moderate Buy ,Get Free Report ,Venture Fund ,Funds Management ,Disc Medicine Daily ,Nasdaq Iron ,Iron ,Medical ,Boost Price Target ,